Using Gabapentin to Control Hot Flashes with ADT

A small phase III, randomized, double blind, placebo controlled trial of Gabapentin which looked at the Management of hot flashes in men on a hormone blockade (ADT) was recently completed and published in the March 2009 journal of the Ann of Oncology. One of the most common and bothersome side effects of a hormone blockade [...]

Can Bone Pain Predict Survival in Men with Metastatic Hormone-Refractory Prostate Cancer Treated with Docetaxel? What are the Implications?

A small study of 145 men with asymptomatic metastatic hormone-refractory prostate cancer (HRPC) was conducted to determine the benefit of starting early chemotherapy with docetaxel. Collected data were analyzed from these subjects who were treated with chemotherapy between February 2000 and June 2002 in one French center. The men were categorized into three groups according [...]

Support Prostate Cancer Research Funding NOW

The Department of Defense manages a significant fund given by congress to finance high risk and high impact research. One of the specific diseases that is funded is prostate cancer. In my personal opinion this particular program has had a significant effect on our lives. Unfortunately, prostate cancer has continued to take a back seat [...]

A Good Reason To Learn About Your Cancer

A report published in the April 1 issue of Cancer stated that Dr. Stacy Gray, as lead investigator from the Dana-Farber Cancer Institute in Boston, has released some findings about the role internet research plays on the quality of care received by cancer survivors. Her main conclusion was that cancer survivors who research their disease [...]

Go to Top